Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novavax Inc NVAX

Healthcare Biotechnology
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID... see more

Recent & Breaking News (NDAQ:NVAX)

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Novavax, Inc. (NVAX) Investors

PR Newswire December 30, 2021

NOVAVAX SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novavax, Inc. - NVAX

PR Newswire December 29, 2021

FINAL DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX

PR Newswire December 29, 2021

NVAX ALERT: Thornton Law Firm Reminds Novavax, Inc. Investors of Securities Class Action Lawsuit

Newsfile December 29, 2021

Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India

PR Newswire December 28, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors Jan. 11th Deadline in Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys

Newsfile December 27, 2021

Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm

Newsfile December 25, 2021

NVAX CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces to Novavax, Inc. of Deadline in Securities Fraud Class Action Lawsuit

PR Newswire December 23, 2021

Novavax and SK bioscience Expand Manufacturing Agreement

PR Newswire December 23, 2021

NOVAVAX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novavax, Inc. - NVAX

PR Newswire December 22, 2021

Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies

PR Newswire December 22, 2021

NOVAVAX, INC. (NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc.

Newsfile December 22, 2021

Thornton Law Firm Reminds Novavax, Inc. (NVAX) Investors of Securities Class Action Lawsuit

Newsfile December 22, 2021

Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study

PR Newswire December 21, 2021

World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine

PR Newswire December 21, 2021

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Novavax, Inc. Investors With Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX

PR Newswire December 21, 2021

NOVAVAX, INC. (NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc.

Newsfile December 20, 2021

World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine

PR Newswire December 20, 2021

European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

PR Newswire December 20, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors to Jan. 11th Deadline in Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys

Newsfile December 20, 2021